AU2467395A - Novel ophthalmologic uses of protein c - Google Patents

Novel ophthalmologic uses of protein c

Info

Publication number
AU2467395A
AU2467395A AU24673/95A AU2467395A AU2467395A AU 2467395 A AU2467395 A AU 2467395A AU 24673/95 A AU24673/95 A AU 24673/95A AU 2467395 A AU2467395 A AU 2467395A AU 2467395 A AU2467395 A AU 2467395A
Authority
AU
Australia
Prior art keywords
protein
novel ophthalmologic
ophthalmologic uses
novel
ophthalmologic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24673/95A
Inventor
Thomas L Steinemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arkansas
Original Assignee
University of Arkansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arkansas filed Critical University of Arkansas
Publication of AU2467395A publication Critical patent/AU2467395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU24673/95A 1994-05-04 1995-05-03 Novel ophthalmologic uses of protein c Abandoned AU2467395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23764994A 1994-05-04 1994-05-04
US237649 1994-05-04
PCT/US1995/005510 WO1995030429A1 (en) 1994-05-04 1995-05-03 Novel ophthalmologic uses of protein c

Publications (1)

Publication Number Publication Date
AU2467395A true AU2467395A (en) 1995-11-29

Family

ID=22894594

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24673/95A Abandoned AU2467395A (en) 1994-05-04 1995-05-03 Novel ophthalmologic uses of protein c

Country Status (3)

Country Link
US (2) US6656490B1 (en)
AU (1) AU2467395A (en)
WO (1) WO1995030429A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
ES2384099T3 (en) 2001-06-13 2012-06-29 The University Of Sydney Protein C for wound healing
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
WO2006014839A2 (en) * 2004-07-23 2006-02-09 The University Of Rochester Activated protein c inhibits undesirable effects of plasminogen activator in the brain
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
EP2869833B1 (en) 2012-07-04 2018-04-04 ZZ Biotech LLC. Activated protein c for use in the treatment of inflammatory skin disorders
WO2015157791A1 (en) 2014-04-16 2015-10-22 The University Of Sydney Treatment of abnormal cutaneous scarring
JP6655610B2 (en) 2014-05-29 2020-02-26 グローコス コーポレーション IMPLANT WITH CONTROLLED DRUG DELIVERY FUNCTION AND METHOD OF USING THE SAME
US11925578B2 (en) 2015-09-02 2024-03-12 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
US11058750B2 (en) * 2015-12-03 2021-07-13 Mor Research Applications Ltd. Compositions and methods for treatment of ocular diseases
US11318043B2 (en) 2016-04-20 2022-05-03 Dose Medical Corporation Bioresorbable ocular drug delivery device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240163A (en) * 1979-01-31 1980-12-23 Galin Miles A Medicament coated intraocular lens
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US4849403A (en) * 1985-05-29 1989-07-18 Pentapharm Ag Protein C activator, methods of preparation and use thereof
JP2739050B2 (en) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 Anticoagulant
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system

Also Published As

Publication number Publication date
US6656490B1 (en) 2003-12-02
US6872404B1 (en) 2005-03-29
WO1995030429A1 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
AU4597596A (en) Prevention of protein aggregation
AU5721798A (en) Human mage-like protein
AU6030398A (en) Human proteins
AU4514193A (en) Bone formation-inducing protein
AU2548097A (en) Formulations of ob protein
AU7317496A (en) Activation of p53 protein
AU4329396A (en) Use of 3,4-diphenylchromans
AU2749395A (en) Medical use of bromelain
AU3902297A (en) Two human nsp-like proteins
AU2467395A (en) Novel ophthalmologic uses of protein c
AU4750097A (en) Human reg i-gamma protein
AU5389096A (en) Human hematopoietic-specific protein
AU4480697A (en) Human nm23-like protein
AU4824197A (en) Novel human lim proteins
AU4593397A (en) Two human cathepsin proteins
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU9017598A (en) Human frezzled-like protein
AU4489196A (en) Novel medical use of heme products
AU7520396A (en) Abl-interactor protein
AU1181897A (en) Medical use of proteases
AU5707498A (en) Novel human membrane protein
AU5621798A (en) Human pathogenesis-related protein
AU4526396A (en) Preparation of anhydropolyamino acids
AU1870295A (en) Novel derivatives of tetramethylcyclopropane